Hepatic encephalopathy: How to improve the management in the intensive care unit?;Encéphalopathie hépatique : comment optimiser la prise en charge en réanimation ?

Reanimation

Volumn 16, Issue 6, 2007, Pages 498-503

  Francoz, C ^a   Durand, F ^a  

^a Service d'Hépatologie HÔpital Beaujon   (France)

Author keywords

Acute liver failure; Ammonia; Coma; Encephalopathy; Prognosis

Indexed keywords

ACARBOSE; AMMONIA; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE; BENZOIC ACID; BROMOCRIPTINE; CARNITINE; DIURETIC AGENT; FLUMAZENIL; LACTULOSE; LEVODOPA; METRONIDAZOLE; MORPHINE; NEOMYCIN; ORNITHINE ASPARTATE; PHENYTOIN; RIFAMPICIN; SEDATIVE AGENT; VALPROIC ACID;

BACTERIUM; CLINICAL FEATURE; COMA; CONSCIOUSNESS; DISEASE SEVERITY; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HOSPITAL PATIENT; HUMAN; INFECTION; INFLAMMATION; INTENSIVE CARE UNIT; INTESTINE FLORA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MENTAL DISEASE; NEUROTOXICITY; NEUROTRANSMISSION; PATHOGENESIS; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; SHORT SURVEY;

EID: 36049052097     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reaurg.2007.09.020     Document Type: Short Survey

References (16)

1. Williams R. Review article: bacterial flora and pathogenesis in hepatic encephalopathy. Aliment Pharmacol Ther 25 Suppl. 1 (2007) 17-22
2. Wright G., and Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol 21 (2007) 95-110
3. Blei A.T. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol 40 (2004) 327-330
4. Shawcross D.L., Davies N.A., Williams R., and Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40 (2004) 247-254
5. Christensen E., Krintel J.J., Hansen S.M., Johansen J.K., and Juhl E. Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis. Survival and prognostic factors. Scand J Gastroenterol 24 (1989) 999-1006
6. Bustamante J., Rimola A., Ventura P.J., Navasa M., Cirera I., Reggiardo V., et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30 (1999) 890-895
7. Wehler M., Kokoska J., Reulbach U., Hahn E.G., and Strauss R. Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 34 (2001) 255-261
8. Stewart CA, Malinchoc M, Kim WR, Kamath PS. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 2007;13:1366-71
9. Plauth M., Merli M., Kondrup J., Weimann A., Ferenci P., and Muller M.J. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 16 (1997) 43-55
10. Marchesini G., Marzocchi R., Noia M., and Bianchi G. Branched-chain amino acid supplementation in patients with liver diseases. J Nutr 135 (2005) 1596S-1601S
11. Als-Nielsen B., Gluud L.L., and Gluud C. Nonabsorbable disaccharides for hepatic encephalopathy. Cochrane Database Syst Rev (2004) CD003044
12. Strauss E., Tramote R., Silva E.P., Caly W.R., Honain N.Z., Maffei R.A., et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology 39 (1992) 542-545
13. Bass N.M. Review article: the current pharmacological therapies for hepatic encephalopathy. Aliment Pharmacol Ther 25 Suppl 1 (2007) 23-31
14. Goulenok C., Bernard B., Cadranel J.F., Thabut D., Di Martino V., Opolon P., et al. Flumazenil versus placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther 16 (2002) 361-372
15. Choi J.Y., Bae S.H., Yoon S.K., Cho S.H., Yang J.M., Han J.Y., et al. Preconditioning by extracorporeal liver support (MARS™) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study. Liver Int 25 (2005) 740-745
16. Mechtcheriakov S., Graziadei I.W., Mattedi M., Bodner T., Kugener A., Hinterhuber H.H., et al. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl 10 (2004) 77-83